Shenyang Xingqi Pharmaceutical Co.,Ltd.

SZSE:300573 Voorraadrapport

Marktkapitalisatie: CN¥14.6b

Shenyang Xingqi PharmaceuticalLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Shenyang Xingqi PharmaceuticalLtd heeft een totaal eigen vermogen van CN¥1.6B en een totale schuld van CN¥230.2M, wat de schuld-eigenvermogensverhouding op 14.1% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥2.2B en CN¥558.0M. De EBIT Shenyang Xingqi PharmaceuticalLtd is CN¥389.8M waardoor de rentedekking -190.1 is. Het heeft contanten en kortetermijnbeleggingen van CN¥503.3M.

Belangrijke informatie

14.1%

Verhouding schuld/eigen vermogen

CN¥230.18m

Schuld

Rente dekkingsratio-190.1x
ContantCN¥503.31m
AandelenCN¥1.63b
Totaal verplichtingenCN¥558.01m
Totaal activaCN¥2.19b

Recente financiële gezondheidsupdates

Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Jun 28
Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Recent updates

Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Oct 23
Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

Sep 08
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

Aug 19
With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Jul 24
What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Jun 28
Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

May 21
Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

May 10
After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

May 07
We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Mar 15
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥947.7M ) 300573 } overtreffen de korte termijn passiva ( CN¥483.3M ).

Langlopende schulden: De kortetermijnactiva 300573 ( CN¥947.7M ) overtreffen de langetermijnschulden ( CN¥74.8M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 300573 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 300573 is de afgelopen 5 jaar gedaald van 15.9% naar 14.1%.

Schuldendekking: De schuld van 300573 wordt goed gedekt door de operationele kasstroom ( 194.3% ).

Rentedekking: 300573 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y